|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Net Operating Real Estate Investments | ||||||||||||||||||||
| Net Real Estate held for sale | ||||||||||||||||||||
| Total Net Real Estate Investments | ||||||||||||||||||||
| Loans and leases receivable, net amount | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Consolidated Entity, Excluding Consolidated VIE | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Common stock investments | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total common stock investments | ||||||||||||||||||||
| Equity method investments ($0 and $1,714 with related parties, respectively) | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total equity method investments ($0 and $1,714 with related parties, respectively) | ||||||||||||||||||||
| Mortgage loans, held-for-investment, net | ||||||||||||||||||||
| Accrued interest and dividends | ||||||||||||||||||||
| Preferred stock investments, at fair value | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total preferred stock investments, at fair value | ||||||||||||||||||||
| Accrued interest and dividends, net | ||||||||||||||||||||
| CMBS structured pass-through certificates, at fair value | ||||||||||||||||||||
| CMBS Structured Pass Through Certificates | ||||||||||||||||||||
| Change in unrealized gain (loss) on MSCR Notes | ||||||||||||||||||||
| Change in unrealized gain (loss) on mortgage backed securities | ||||||||||||||||||||
| Stock warrant investments, at fair value | ||||||||||||||||||||
| Accounts receivable and other assets | ||||||||||||||||||||
| Due from brokers for securities sold, not yet settled | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Secured financing agreements, net | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total secured financing agreements, net | ||||||||||||||||||||
| Master repurchase agreements | ||||||||||||||||||||
| Unsecured notes, net | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total unsecured notes, net | ||||||||||||||||||||
| Mortgages payable, net | ||||||||||||||||||||
| Mortgages payable held for sale, net | ||||||||||||||||||||
| Accounts payable and other accrued liabilities | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Bonds payable held in variable interest entities, at fair value | ||||||||||||||||||||
| Total bonds payable held in variable interest entities, at fair value | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Redeemable Preferred stock | ||||||||||||||||||||
| Redeemable Series B Preferred Stock | ||||||||||||||||||||
| Redeemable Series C Preferred Stock | ||||||||||||||||||||
| Total redeemable Preferred stock | ||||||||||||||||||||
| Redeemable noncontrolling interests in the OP | ||||||||||||||||||||
| Stockholders' Equity: | ||||||||||||||||||||
| Stockholders' equity attributable to noncontrolling interest | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Noncontrolling interest in Subsidiary | ||||||||||||||||||||
| Preferred stock, value, outstanding | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Total preferred stock, value, outstanding | ||||||||||||||||||||
| Common stock, value, outstanding | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings (accumulated deficit) | ||||||||||||||||||||
| Series A Preferred stock held in treasury at cost | ||||||||||||||||||||
| Common stock held in treasury at cost | ||||||||||||||||||||
| Total Stockholders' Equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
Loading...